Atossa Genetics, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Seattle WA United States (2009)

Organization Overview

First Clinical Trial
2016
NCT02540330
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Atossa Genetics, Inc. | Atossa Therapeutics, Inc.